All In Biotech

Drug Trial Radar · NCT06742996

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

A Phase 3 Randomized Double-Blind Multicenter Study of Sonrotoclax Plus Zanubrutinib Versus Placebo Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma

Last checked: Nov 19, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Mar 5, 2025

Primary completion

Aug 31, 2028

Study completion Mar 30, 2032

Sponsor

Lead sponsor
BeOne MedicinesBeOne Medicines (BeiGene) (ONC)
Sponsor type
Industry
First posted
Dec 19, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to compare how well sonrotoclax plus zanubrutinib works versus zanubrutinib plus placebo in treating adults with relapsed/refractory (R/R) mantle cell lymphoma (MCL). This study will also look at the safety of sonrotoclax plus zanubrutinib versus zanubrutinib plus placebo.

Conditions

  • Mantle Cell Lymphoma
  • B Cell Lymphoma

Interventions

  • SonrotoclaxDrug

    Administered orally

  • ZanubrutinibDrug

    Administered orally

  • PlaceboDrug

    Administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-Free Survival (PFS) as assessed by Blinded Independent Review Committee (BIRC)Time frame: Approximately 41 months

Locations

145 sites in 17 countries. Site status is shown where the registry gives one.

  • University of Alabama At Birmingham Hospital

    Birmingham, Alabama · Recruiting

  • University of Arizona Cancer Center

    Tucson, Arizona · Recruiting

  • Ucsf Fresno

    Fresno, California · Recruiting

  • Kaiser Permanente Southern California

    Irvine, California · Recruiting

  • Yale University Yale Cancer Center

    New Haven, Connecticut · Recruiting

  • Memorial Cancer Institute, Memorial Healthcare System

    Pembroke Pines, Florida · Recruiting

  • Cleveland Clinic Florida

    Weston, Florida · Recruiting

  • Rush University Medical Center

    Chicago, Illinois · Recruiting

  • University of Chicago Medical Center

    Chicago, Illinois · Recruiting

  • Fort Wayne Medical Oncology and Hematology

    Fort Wayne, Indiana · Recruiting

  • Mission Cancer and Blood

    Waukee, Iowa · Recruiting

  • Our Lady of the Lake Hospital

    Baton Rouge, Louisiana · Recruiting

  • The University of Maryland Greenebaum Comprehensive Cancer Center

    Baltimore, Maryland · Recruiting

  • Dana Farber Cancer Institute Longwood Medical Center

    Boston, Massachusetts · Recruiting

  • University of Michigan

    Ann Arbor, Michigan · Recruiting

  • The Cancer and Hematology Centers

    Grand Rapids, Michigan · Recruiting

  • Mayo Clinic Rochester

    Rochester, Minnesota · Recruiting

  • Hattiesburg Hematology and Oncology Clinic

    Hattiesburg, Mississippi · Recruiting

  • Washington University School of Medicine

    St Louis, Missouri · Recruiting

  • Nebraska Cancer Specialists St Francis Grand Island

    Grand Island, Nebraska · Recruiting

  • Nebraska Cancer Specialists

    Omaha, Nebraska · Recruiting

  • The Valley Hospital, Inc

    Paramus, New Jersey · Recruiting

  • Memorial Sloan Kettering Cancer Center Mskcc

    New York, New York · Recruiting

  • Atrium Health Levine Cancer Institute (Lci)

    Charlotte, North Carolina · Recruiting

  • Duke University

    Durham, North Carolina · Recruiting

  • Atrium Health Wake Forest Baptist

    Winston-Salem, North Carolina · Recruiting

  • University Hospitals

    Cleveland, Ohio · Recruiting

  • Cleveland Clinic Foundation

    Cleveland, Ohio · Recruiting

  • Ohio State University Comprehensive Cancer Center

    Columbus, Ohio · Recruiting

  • Ohio Health Research Institute

    Columbus, Ohio · Recruiting

  • Penn State Milton S Hershey Medical Center

    Hershey, Pennsylvania · Recruiting

  • McGlinn Cancer Institute

    West Reading, Pennsylvania · Recruiting

  • Tennessee Oncology Nashville St Thomas Midtown Clinic

    Nashville, Tennessee · Recruiting

  • Tennessee Oncology

    Nashville, Tennessee · Recruiting

  • Md Anderson Cancer Center

    Houston, Texas · Recruiting

  • Texas Oncology Austin Midtown

    Round Rock, Texas · Recruiting

  • University of Virginia

    Charlottesville, Virginia · Recruiting

  • Virgina Cancer Specialists

    Gainesville, Virginia · Recruiting

  • Vcu Massey Cancer Center

    Richmond, Virginia · Recruiting

  • Northwest Cancer Specialist, Pc(Us Oncology Research)

    Vancouver, Washington · Recruiting

Showing 40 of 145 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.